Lv21
190 积分 2023-01-11 加入
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
9小时前
待确认
A validation study of the 2021 CKD-EPI equations: data from two cohort studies in Nanjing, China
9小时前
已完结
Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome
13天前
已完结
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
21天前
已完结
Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial
21天前
已完结
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
21天前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
22天前
已完结
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
23天前
已完结
Clinical features of patients with mutations in genes for nanophthalmos
2个月前
已完结
Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study
2个月前
已完结
皖公网安备34019202002308
